Literature DB >> 19719259

Deciphering the fluorescence resonance energy transfer signature of 3-pyrazolyl 2-pyrazoline in transport proteinous environment.

Paltu Banerjee1, Smritimoy Pramanik, Arindam Sarkar, Subhash Chandra Bhattacharya.   

Abstract

In the present investigation, an attempt has been made to study the interaction of newly synthesized bioactive compound 3-pyrazolyl 2-pyrazoline (PZ) with model transport proteins, bovine serum albumin (BSA), and human serum albumin (HSA) employing steady state and time-resolved fluorescence technique. We have focused on fluorescence resonance energy transfer (FRET) between excited tryptophan in transport proteins to transport-proteins-bound PZ. An efficient Forster-type resonance energy transfer from the tryptophan residues to PZ indicates that PZ binds in the vicinity of the tryptophan residue. Binding of protein to that bioactive compound without changing conformation of primary and secondary structure of protein has been monitored using circular dichroism (CD) study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19719259     DOI: 10.1021/jp811479r

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  4 in total

1.  Binding and fluorescence resonance energy transfer (FRET) of ruthenium(II)-bipyridine-calixarene system with proteins--experimental and docking studies.

Authors:  P Muthu Mareeswaran; D Maheshwaran; E Babu; S Rajagopal
Journal:  J Fluoresc       Date:  2012-06-15       Impact factor: 2.217

2.  Interaction of organoruthenium(II)-polypyridyl complexes with DNA and BSA.

Authors:  Aleksandra Margetić; Stefan Nikolić; Sanja Grgurić-Šipka; Miroslava T Vujčić
Journal:  Biometals       Date:  2022-06-16       Impact factor: 3.378

3.  The Spectroscopy Study of the Binding of an Active Ingredient of Dioscorea Species with Bovine Serum Albumin with or without Co(2+) or Zn(2+).

Authors:  He-Dong Bian; Xia-Lian Peng; Fu-Ping Huang; Di Yao; Qing Yu; Hong Liang
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-04       Impact factor: 2.629

4.  The Interaction of Temozolomide with Blood Components Suggests the Potential Use of Human Serum Albumin as a Biomimetic Carrier for the Drug.

Authors:  Marta Rubio-Camacho; José A Encinar; María José Martínez-Tomé; Rocío Esquembre; C Reyes Mateo
Journal:  Biomolecules       Date:  2020-07-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.